Rare Disease Landscape: Will the Blockbuster Model Be Replaced?
Expert Opinion on Orphan Drugs - United Kingdom
doi 10.1517/21678707.2014.924850
Full Text
Open PDFAbstract
Available in full text
Date
May 28, 2014
Authors
Publisher
Informa Healthcare